AI Transforms Indian Healthcare with Diagnostic Support

Artificial Intelligence is rapidly evolving into a strategic pillar within India's healthcare delivery system, moving beyond mere support functions. A recent "Healthcare AI in India in 2026" report highlights that 67% of patients now consult AI engines before scheduling healthcare consultations, significantly influencing patient acquisition in urban markets. This trend, underscored at the Aarambh AI Healthcare Summit in Gurgaon, indicates a fundamental shift in how patients interact with the healthcare ecosystem, leveraging AI for initial information and guidance.

While the AI technology itself is mature for specific applications, its broad deployment in clinical workflows and regulatory frameworks is still developing. Large private hospital groups like Manipal, Apollo, and Max are deploying AI diagnostic tools, primarily as a "second pair of eyes" for radiology support in high-volume procedures such as chest X-ray screening and diabetic retinopathy detection. This approach focuses on flagging potential issues rather than replacing human diagnostics. AI is also crucial for expanding telemedicine accessibility from 100 million to over 500 million patients by overcoming digital literacy and language barriers.

The market for AI in patient communication and engagement alone is projected to reach ₹1,800-2,200 crore by 2026, demonstrating a robust 50% annual growth. Companies like Qure.ai are at the forefront, developing AI-powered imaging tools for detecting critical conditions such as tuberculosis, stroke, and lung abnormalities. As the ecosystem matures, AI is expected to streamline operations, improve diagnostic accuracy, and make healthcare more accessible and efficient across India, particularly in underserved regions.